| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Revenue | $80.0M | +2752.0% |
| R&D Expense | $63.4M | -11.7% |
| SG&A Expense | $36.4M | -12.5% |
| Operating Income | -$21.9M | +80.2% |
| Net Income | -$9.7M | +90.0% |
| EPS (Basic) | -$0.16 | +89.9% |
| EPS (Diluted) | -$0.16 | +89.9% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $58.2M | +127.7% |
| Current Assets | $249.9M | +3.2% |
| Total Assets | $260.7M | +1.2% |
| Current Liabilities | $11.0M | -19.2% |
| Total Liabilities | $17.7M | -21.4% |
| Stockholders' Equity | $243.0M | +3.3% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$2.2M | +97.6% |
| Capital Expenditures | $278K | -45.3% |
| Investing Cash Flow | $32.2M | +187.8% |
| Financing Cash Flow | $2.7M | -97.7% |
| Free Cash Flow | -$2.5M | +97.3% |